John S. Albin, Ph.D. - Publications

Affiliations: 
2012 Microbiology, Immunology and Cancer Biology University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Virology Biology, Immunology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Richards C, Albin JS, Demir Ö, Shaban NM, Luengas EM, Land AM, Anderson BD, Holten JR, Anderson JS, Harki DA, Amaro RE, Harris RS. The Binding Interface between Human APOBEC3F and HIV-1 Vif Elucidated by Genetic and Computational Approaches. Cell Reports. PMID 26628363 DOI: 10.1016/j.celrep.2015.10.067  0.96
2014 Land AM, Shaban NM, Evans L, Hultquist JF, Albin JS, Harris RS. APOBEC3F determinants of HIV-1 Vif sensitivity. Journal of Virology. 88: 12923-7. PMID 25142588 DOI: 10.1128/JVI.02362-14  0.96
2014 Albin JS, Brown WL, Harris RS. Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus. Virology. 450: 49-54. PMID 24503066 DOI: 10.1016/j.virol.2013.11.041  0.96
2013 Bohn MF, Shandilya SM, Albin JS, Kouno T, Anderson BD, McDougle RM, Carpenter MA, Rathore A, Evans L, Davis AN, Zhang J, Lu Y, Somasundaran M, Matsuo H, Harris RS, et al. Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain. Structure (London, England : 1993). 21: 1042-50. PMID 23685212 DOI: 10.1016/j.str.2013.04.010  0.96
2013 Albin JS, Anderson JS, Johnson JR, Harjes E, Matsuo H, Krogan NJ, Harris RS. Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F. Journal of Molecular Biology. 425: 1172-82. PMID 23318957 DOI: 10.1016/j.jmb.2013.01.010  0.96
2013 Albin JS, Harris RS. APOBECs and their role in proviral DNA synthesis Human Immunodeficiency Virus Reverse Transcriptase: a Bench-to-Bedside Success. 253-280. DOI: 10.1007/978-1-4614-7291-9_12  0.96
2010 Albin JS, LaRue RS, Weaver JA, Brown WL, Shindo K, Harjes E, Matsuo H, Harris RS. A single amino acid in human APOBEC3F alters susceptibility to HIV-1 Vif. The Journal of Biological Chemistry. 285: 40785-92. PMID 20971849 DOI: 10.1074/jbc.M110.173161  0.96
2010 Albin JS, Haché G, Hultquist JF, Brown WL, Harris RS. Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function. Journal of Virology. 84: 10209-19. PMID 20686027 DOI: 10.1128/JVI.00632-10  0.96
2010 Refsland EW, Stenglein MD, Shindo K, Albin JS, Brown WL, Harris RS. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Research. 38: 4274-84. PMID 20308164 DOI: 10.1093/nar/gkq174  0.96
2010 Albin JS, Harris RS. Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. Expert Reviews in Molecular Medicine. 12: e4. PMID 20096141 DOI: 10.1017/S1462399409001343  0.96
2008 Haché G, Shindo K, Albin JS, Harris RS. Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3G. Current Biology : Cb. 18: 819-24. PMID 18501607 DOI: 10.1016/j.cub.2008.04.073  0.96
Show low-probability matches.